← Research library

Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects

Animal research · 1996

What was studied
Mouse hepatic-enzyme screening and sensitized guinea-pig anaphylaxis experiments
Main finding
ADK-559/591/676/677 weakly inhibited hepatic monooxygenases; ADK-709/790/828/829/910/918 induced P450. The author also reports fewer anaphylaxis deaths with ADK-828 and ADK-829 in guinea pigs. Different controls and OCR table ambiguities prevent a reliable cross-compound ranking.

Study data at a glance

Participants or experimental model
Mouse hepatic-enzyme screening and sensitized guinea-pig anaphylaxis experiments
Reported results
ADK-559/591/676/677 weakly inhibited hepatic monooxygenases; ADK-709/790/828/829/910/918 induced P450. The author also reports fewer anaphylaxis deaths with ADK-828 and ADK-829 in guinea pigs. Different controls and OCR table ambiguities prevent a reliable cross-compound ranking.
Study limitations and source details

Study limitations

  • Original structures and tables require checking against the scan; transcription errors are possible.
  • Enzyme induction does not establish detoxification benefits or predict safe human drug combinations.
  • Animal anaphylaxis results are not evidence for treating allergy in people; proposed adjunct uses were development suggestions.

Source details

Dissertation; OCR reproduction · Dissertation abstract transcription

Selected source passages checked; complete methods and risk of bias not appraised.

Sources checked

Citation

Animal / experimentalRussian-language source

T. G. Khlopushina. Influence of hereditary and environmental factors on cytochrome P450 metabolic activity and drug effects Doctoral dissertation author’s abstract. Moscow, 1996

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Bromantane

A synthetic adamantane drug, also called Ladasten, studied in Russian fatigue and stress research.

Chlodantane

N-(adamantan-2-yl)-4-chlorobenzamide (ADK-910), an experimental small molecule with an adamantane cage joined to a chlorobenzamide. Russian studies examined temperature stress and physical workload.

ADK-918

The para-bromobenzamide counterpart of Chlodantane, N-(adamantan-2-yl)-4-bromobenzamide. It is chemically distinct from Bromantane.

ADK-559

ADK-559 is an experimental N-substituted adamantylpiperazine. A historical screen reported weak inhibition of hepatic monooxygenases, enzymes involved in drug metabolism. The source does not identify the N-substituent.

ADK-591

ADK-591 is an experimental N-substituted adamantylpiperazine. A historical screen reported weak inhibition of hepatic monooxygenases, enzymes involved in drug metabolism. The source does not identify the N-substituent.

ADK-676

ADK-676 is an experimental N-substituted adamantylpiperazine. A historical screen reported weak inhibition of hepatic monooxygenases, enzymes involved in drug metabolism. The source does not identify the N-substituent.

ADK-677

ADK-677 is an experimental N-substituted adamantylpiperazine. A historical screen reported weak inhibition of hepatic monooxygenases, enzymes involved in drug metabolism. The source does not identify the N-substituent.

ADK-790

An experimental adamantane–benzimidazole compound studied for its effects on liver enzymes that metabolize drugs.

ADK-828

Adamantylidene-2,6-diacetonitrile, an experimental adamantane derivative. Animal studies examined induction of liver drug-metabolizing enzymes and anaphylactic reactions.

ADK-829

An experimental bromophenyl benzamide attached to an adamantane group, identified in a historical liver-enzyme screen.

Editorial policy and evidence standards